This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Luteinizing Hormone

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Luteinizing Hormone Means in Everyday Medical Language

Luteinizing Hormone, often called LH, is a natural hormone made by the pituitary gland, a small gland at the base of the brain. In women, LH plays a key role in the menstrual cycle by helping the ovaries release eggs and prepare the uterus for pregnancy. In men, LH signals the testes to produce testosterone, the male hormone important for sexual development and other body functions.

Why Luteinizing Hormone Can Matter in Cancer Care

LH is important in cancer care because some cancers, like prostate cancer, depend on hormones such as testosterone to grow. Since LH controls testosterone production in men, treatments often target LH or the hormones that regulate it to lower testosterone levels and slow cancer growth. For example, hormone therapies called luteinizing hormone-releasing hormone (LHRH) agonists or antagonists affect the pituitary gland’s release of LH, which in turn lowers testosterone. These treatments can be combined with other therapies to manage hormone-sensitive cancers.

What Patients Might See or Hear About Luteinizing Hormone

Patients may encounter the term LH or luteinizing hormone in lab test results, treatment plans, or discussions about hormone therapies. It may also appear under other names like interstitial cell-stimulating hormone or lutropin. Some hormone therapies, such as Camcevi, are LHRH agonists that initially cause a temporary rise in LH and testosterone before lowering them. This temporary rise is sometimes called a "testosterone flare." Understanding these terms can help patients ask informed questions about their treatment.

Common Sources of Confusion and Related Terms

LH is closely linked to other hormones like follicle-stimulating hormone (FSH) and luteinizing hormone-releasing hormone (LHRH), which controls LH release. These terms can appear in reports or medication names, sometimes causing confusion. For example, LHRH agonists and antagonists are types of hormone therapies that affect LH levels differently. Comparing wording in medical reports and asking the care team for clarification can help avoid misunderstandings.

How to Read Luteinizing Hormone in Context

Seeing the term LH alone does not mean a diagnosis or treatment decision. It is important to understand how LH relates to a person’s specific situation, such as their cancer type, treatment plan, or lab results. Patients should ask their care team what LH means in their own reports or discussions to get clear, personalized information.

Safety and Next Steps

This information is educational and does not replace medical advice. If you see luteinizing hormone mentioned in your medical records or hear it during visits, the best next step is to ask your care team how it applies to your care. They can explain what LH means for your diagnosis, treatment, or monitoring and help you understand any hormone therapies involved.

Sources

Public source information used for this glossary entry includes: